跳至主要内容
临床试验/JPRN-UMIN000013022
JPRN-UMIN000013022尚未招募4 期

Multicentre, randomized, double blind, placebo-controlled study to evaluate the effect of pancreatic enzyme replacement therapy on glucose metabolism, nutritional parameters, incretin response and beta-cell function in patients with diabetes mellitus and exocrine pancreatic insufficiency - Pancreatic enzyme replacement therapy in diabetes mellitus and exocrine pancreatic insufficiency

First Department of Internal Medicine, Szeged0 个研究点目标入组 120 人开始时间: 2014年2月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional,observational

入排标准

年龄范围
18years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • -Patients with any severe diseases -Any type of malignancy -Any history of gastrointestinal surgery, -Any known reason for maldigestion or malabsorption -Any history of alcohol or drug abuse -Proven gastroparesis or diarrhea -Females with existing or intended pregnancy or breast-feeding, or not using adequate birth control

研究者

发起方
First Department of Internal Medicine, Szeged

相似试验

进行中(未招募)
1 期
Multicentre, double-blind, randomized, placebo-controlled, parallel-group, clinical trial to evaluates the clinical efficacy and safety of immunotherapy with purified major allergen Alt a 1 in patients with allergic rhinoconjunctivitis with or without mild to moderate asthma, sensitized the fungus Alternaria alternata
EUCTR2010-024440-15-ESDIATER Laboratorio de Diagnostico y Aplicaciones Terapéuticas S.A.
进行中(未招募)
1 期
Study on the treatment of the mild congnitive impairment due to Alzheimer's disease with Zinc Sulphate
EUCTR2019-000604-15-ITIVERSITÀ DEGLI STUDI G. D'ANNUNZIO CHIETI-PESCARA215
进行中(未招募)
1 期
Multicentre, randomized, double-blind, placebo-controlled, non-commercial clinical trial to evaluate the efficacy and safety of specific anti-SARS-CoV-2 immunoglobulin in the treatment of COVID-19CoronaVirus Disease 2019
EUCTR2020-005410-18-PLSamodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie Samodzielny Publiczny Zaklad Opieki Zdrowotnej480
招募中
1 期
Study to evaluate the efficacy and safety of low-dose aspirin as an add-on to standard therapy in patients with bipolar disorder (ASPIRIN BD)Bipolar Affective DisorderMedDRA version: 21.1Level: LLTClassification code: 10004908Term: Bipolar affective disorder Class: 10037175
CTIS2024-516584-86-00Instytut Psychiatrii I Neurologii100
进行中(未招募)
不适用
Multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the short-term efficacy and safety of two different treatment regimens of Betamethasone valerate 2.25 mg medicated plaster in patients with chronic tendinopathies of the upper and lower limbs
EUCTR2012-005030-11-ITIBSA INSTITUT BIOCHIMIQUE SA